Efficacy of a Chronic Care Model Supported by Self Monitoring of Blood Glucose With BGStar Over Usual Care in Improving Glycemic Control in Patients With Type 2 Diabetes Not Treated With Insulin

Inclusion Criteria: * Males and females * Age ≥ 45 years * Type 2 diabetes * First access at the diabetes clinic * Any diabetes duration * HbA1c \>7.0 and ≤ 9.0% * Already treated with any oral antidiabetic agent (OAD) or requiring the initiation of therapy with OAD * Patients not using SMBG or using SMBG with a frequency ≤1 test/week * Written informed consent Exclusion Criteria: Treatment with insulin or need to start insulin regimens or continuous sub-cutaneous insulin infusion at the first access; Refusal or inability to give informed consent to participate in the study; Conditions / situations such as: * Patients with short life expectancy; * Patients with conditions/concomitant diseases making them non evaluable for the primary efficacy endpoint according to physician's judgment; * Requirement for concomitant treatment that could bias primary evaluation (i.e. corticosteroid treatment); * Patient is the Investigator or any Sub-Investigator, research assistant, pharmacist, study coordinator, other study site staff or relative of study site staff thus considered directly involved in the conduct of the study; * Current addition/abuse of alcohol or drugs; * Patients with any mental condition rendering them unable to understand the nature, scope, and possible consequences of the study; * Pregnant or breast-feeding women; * Patients living too far from investigational center or other conditions reducing the adherence to the protocol; Subjects unlikely or unable to comply with the Protocol requirements (e.g. illiterate, uncooperative, unable to return for follow-up visit, unable to use BGStar unlikely to complete the study)